BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16858363)

  • 1. [Combination of clopidogrel and aspirin was no better than aspirin alone for prevention of atherothrombotic events in stable patients. Results of CHARISMA].
    Granitskiĭ NA
    Kardiologiia; 2006; 46(5):73-5. PubMed ID: 16858363
    [No Abstract]   [Full Text] [Related]  

  • 2. The CHARISMA trial and the REACH registry outcomes.
    Faxon DP; Nesto RW
    J Natl Med Assoc; 2006 Oct; 98(10):1713. PubMed ID: 17052070
    [No Abstract]   [Full Text] [Related]  

  • 3. Contemporary use of clopidogrel in patients with coronary artery disease.
    Parikh SA; Beckman JA
    Curr Cardiol Rep; 2007 Jul; 9(4):257-63. PubMed ID: 17601391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of atherothrombotic incidents. CHARISMA Study (The Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance].
    Erdmann E
    Internist (Berl); 2006 Dec; 47(12):1295-7. PubMed ID: 17096154
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of clopidogrel in managing atherothrombotic cardiovascular disease.
    Eshaghian S; Kaul S; Amin S; Shah PK; Diamond GA
    Ann Intern Med; 2007 Mar; 146(6):434-41. PubMed ID: 17371888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CAPRIE-like subgroups of CHARISMA: a CAPRIEciously biased analysis of an unCHARISMAtic truth.
    Gebel JM
    J Am Coll Cardiol; 2007 Oct; 50(17):1704; author reply 1704-5. PubMed ID: 17950155
    [No Abstract]   [Full Text] [Related]  

  • 7. [Two platelet inhibitors after acute coronary syndrome. Many colleagues are not aware of this].
    MMW Fortschr Med; 2002 Mar; 144(13):50. PubMed ID: 12008695
    [No Abstract]   [Full Text] [Related]  

  • 8. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
    Bhatt DL; Topol EJ;
    Am Heart J; 2004 Aug; 148(2):263-8. PubMed ID: 15308995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.
    Matetzky S; Shenkman B; Guetta V; Shechter M; Beinart R; Goldenberg I; Novikov I; Pres H; Savion N; Varon D; Hod H
    Circulation; 2004 Jun; 109(25):3171-5. PubMed ID: 15184279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clopidogrel with aspirin is the optimal antiplatelet regimen for intracoronary stenting.
    Steinhubl SR; Topol EJ
    J Thromb Thrombolysis; 1999 Jun; 7(3):227-31. PubMed ID: 10373712
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation.
    de Carvalho HC
    Rev Port Cardiol; 1999 Jun; 18(6):657-8. PubMed ID: 10422464
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY).
    Rangé G; Yayehd K; Belle L; Thuaire C; Richard P; Cazaux P; Barbou F; Köning R; Chassaing S; Teiger E; Berthier R; Decomis MP; Claudel JP; Delarche N; Brunel P; De Poli F; Dupouy P; Beygui F; Albert F; Collet JP; Montalescot G;
    Arch Cardiovasc Dis; 2014 Apr; 107(4):225-35. PubMed ID: 24794216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clopidogrel: how good is it and how does it work?
    Santa-Cruz RA; Steinhubl SR
    Curr Cardiol Rep; 2004 Jul; 6(4):264-8. PubMed ID: 15182601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cilostazol, clopidogrel or ticlopidine to prevent sub-acute stent thrombosis: a meta-analysis of randomized trials.
    Schleinitz MD; Olkin I; Heidenreich PA
    Am Heart J; 2004 Dec; 148(6):990-7. PubMed ID: 15632883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
    van Werkum JW; Topcu Y; Postma S; Kelder JC; Hackeng CM; ten Berg JM; Verheugt FW
    Thromb Haemost; 2008 Mar; 99(3):637-9. PubMed ID: 18327417
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
    Tran H; Anand SS
    JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and ticlopidine after routine coronary stenting: the gold standard as of 1999.
    McCullough PA; Marks KR
    J Thromb Thrombolysis; 1999 Jun; 7(3):233-9. PubMed ID: 10373716
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clopidogrel and aspirin versus aspirin alone in prevention of atherothrombotic events. The results of CHARISMA study].
    Gaciong Z
    Kardiol Pol; 2006 May; 64(5):548-51; discussion 551-2. PubMed ID: 16752345
    [No Abstract]   [Full Text] [Related]  

  • 19. Clopidogrel but not Aspirin prevents acute smoking-induced platelet aggregation in patients with stable coronary artery disease.
    Addad F; Chakroune T; Asma A; Abderazek F; Zohra D; Ghrissi I; Hassine M; Gamra H; Elalamy I
    Thromb Res; 2009 Feb; 123(4):640-3. PubMed ID: 18602138
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of and management approaches for the high-risk patient.
    Bhatt DL
    Am J Cardiol; 2006 Dec; 98(12A):22Q-29Q. PubMed ID: 17169626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.